Yiwen Zhang

Dr. Yiwen Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
ZCZhiqiang Chen
Zhiqiang Chen
QHQuanshui Hao
Quanshui Hao
RSRao Sun
Rao Sun
YZYanjing Zhang
Yanjing Zhang
HFHui Fu
Hui Fu
YZYiwen Zhang
Yiwen Zhang
Aims: The aims of the study were to determine the relationship between preoperative geriatric nutritional risk index (GNRI) and the occurrence of postoperative delirium (POD) in elderly patients after cardiac surgery and to evaluate the additive value of GNRI for predicting POD. Methods: The data were extracted from the Multiparameter Intelligent Monitoring in Intensive Care (MIMIC‐IV) database. Patients who underwent cardiac surgery and were aged 65 or older were included. The relationship between preoperative GNRI and POD was investigated using logistic regression. We determined the added predictive value of preoperative GNRI for POD by measuring the changes in the area under the receiver operating characteristic curve (AUC) and calculating the net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: A total of 4286 patients were included in the study, and 659 (16.1%) developed POD. Patients with POD had significantly lower GNRI scores than patients without POD (median 111.1 vs. 113.4, p < 0.001). Malnourished patients (GNRI ≤ 98) had a significantly higher risk of POD (odds ratio, 1.83, 90% CI, 1.42–2.34, p < 0.001) than those without malnutrition (GNRI > 98). This correlation remains after adjusting for confounding variables. The addition of GNRI to the multivariable models slightly but not significantly increases the AUCs (all p > 0.05). Incorporating GNRI increases NRIs in some models and IDIs in all models (all p < 0.05). Conclusions: Our results showed a negative association between preoperative GNRI and POD in elderly patients undergoing cardiac surgery. The addition of GNRI to POD prediction models may improve their predictive accuracy. However, these findings were based on a single‐center cohort and will need to be validated in future studies involving multiple centers.

3 December 2024 in Pain and Therapy
Verified
Journal Article
Open access
PDF file
HPHaobin Peng
Haobin Peng
JWJiajun Wen
Jiajun Wen
MCManli Chen
Manli Chen
ZXZhengyuan Xia
Zhengyuan Xia
YJYing Jiang
Ying Jiang
XWXianping Wu
Xianping Wu
Introduction Single-injection pericapsular nerve group (PENG) block with ropivacaine provides clear analgesic effects in preoperative pain management for hip fractures. However, it suffers from insufficient duration, failing to meet the needs of most patients. This single-center, randomized controlled, observer-blinded trial utilizes a novel combination of liposomal bupivacaine (LB) single-injection PENG block to examine its efficacy, duration, and safety in preoperative analgesia for hip fractures, aiming to develop a new preoperative analgesic protocol. Methods Sixty-six patients with hip fractures received ultrasound-guided single-injection PENG block with LB or ropivacaine after admission. The primary outcome was the static and dynamic pain scores measured at 48 h post-block. Pain scores at 12, 24, 36, 60, and 72 h post-block, rescue analgesia rate, time to first opioid, additional morphine consumption, and adverse events were assessed as the secondary outcomes. Results LB versus ropivacaine group at 48 h post-block, with a median interquartile range (IQR) of 2 (1.0–2.0) versus 3 (2.0–3.0) at static pain score and 2 (1.75–3.0) versus 4 (4.0–5.0) at dynamic pain score. LB group had lower dynamic and static pain scores at other observation points except for the static pain score at 72 h, lower pain intensity [sum of pain intensity difference (SPID)0–24, SPID0–48 and SPID0–72], longer time to first opioid, lower additional morphine consumption, and lower incidence of nausea and vomiting. No significant inter-group differences were detected in other secondary outcomes. Conclusions For preoperative analgesia of hip fractures, LB single-injection PENG block had a similar analgesic intensity and safety as ropivacaine but provided a longer duration of analgesia, reaching 48 h and even extending beyond 60 h, which reduced opioid consumption and extended time to the first opioid. Trial Registration The protocol was registered in www.chictr.org.cn under the identifier ChiCTR2300072939.


18 March 2025 in Redox Biology
Verified
Journal Article
Open access
SHSen Huang
Sen Huang
YXYuxin Xie
Yuxin Xie
ZZZhaochun Zhan
Zhaochun Zhan
FLFengdong Liu
Fengdong Liu
PLPeiyang Liu
Peiyang Liu
XLXin Luo
Xin Luo
Pain hypersensitivity is a hallmark of rheumatoid arthritis (RA); however, the underlying mechanisms and effective therapies remain largely undefined. Emerging studies suggest that neutrophils play a significant role in the pathology of RA, yet their involvement in RA-associated pain is still unclear. The present study investigates whether neutrophil activity contributes to pain pathogenesis in RA. Our flow cytometry analysis reveals that the accumulation and N1 polarization (indicated by the ratio of CD45+CD66b+CD95+ subset) of neutrophils occur in synovial fluid samples from RA patients, positively correlating with pain scores. In the collagen-induced rheumatoid arthritis (CIA) model, mice demonstrate neutrophil accumulation, N1 polarization (indicated by the ratio of CD45+Ly-6G+CD95+ subset), and reactive oxygen species (ROS) production in affected paw tissues. Geranyl hydroquinone (GHQ), a natural meroterpenoid with antioxidative properties, reverses N1 polarization and ROS production in synovial neutrophils from RA patients in vitro. Moreover, a 10-day oral administration of GHQ alleviates pain hypersensitivity and reduces neutrophil accumulation, N1 polarization, and ROS production in CIA mice. Notably, GHQ treatment reverses TNF-α-evoked ROS production in neutrophils in vitro through downregulating gene expression associated with the ROS pathway. Further, liquid chromatography-tandem mass spectrometry and biochemical analyses indicate that GHQ binds to microsomal glutathione S-transferase 3 (MGST3) in neutrophils. In vitro and in vivo evidence demonstrates that the RA-specific analgesic and antioxidative effects of GHQ require MGST3. Lastly, GHQ administration exhibits superior therapeutic effects compared to methotrexate, a first-line disease-modifying antirheumatic drug, in CIA mice. Collectively, our findings indicate that neutrophil accumulation, N1 polarization and ROS production contribute to RA-associated pain, suggesting that targeting these pathways, such as with GHQ, could be a viable strategy for RA treatment.

3 March 2025 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
DXDanru Xie
Danru Xie
YZYanjing Zhang
Yanjing Zhang
FLFeifei Li
Feifei Li
YYYaoheng Yang
Yaoheng Yang
MCMengjiao Che
Mengjiao Che
YZYiwen Zhang
Yiwen Zhang
This study aimed to compare the efficacy and safety of ciprofol-induced doses based on three indices: total body weight (TBW), ideal body weight (IBW), and lean body weight (LBW) in patients with obesity undergoing gastroscopy. In a single-centre, prospective, randomised study conducted at an endoscopy centre, a total of 108 patients aged 18–65 years who underwent painless gastroscopy and had a body mass index (BMI) of 28–39.9 kg/m2 were included. Patients with obesity from the intended study population were randomised to receive a ciprofol infusion (0.4 mg/kg) for the induction of anaesthesia based on TBW (Group T), IBW (Group I), or LBW (Group L). A Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) scale score of < 1 was considered a marker of loss of consciousness, prompting gastroscopy. The primary outcomes were the success rate of anaesthesia for the procedures, and that of general anaesthesia achieved using the initial dose. Secondary outcomes included the frequency of remedial sedation, total ciprofol dose, and adverse events The procedure success rate was 100% in all three groups. Compared to Group L, the general anaesthesia success rate achieved with the initial dose was higher and the frequency of remedial sedation was lower in Groups T and I. Compared to Group L, fewer patients in Group T required additional medication. Compared to Group T, the occurrence of hypoxaemia was lower in the remaining two groups, and Group L had a lower incidence of posterior tongue drops and hypotension. Induction doses of ciprofol based on TBW or IBW provided better anaesthesia than doses based on LBW for gastroscopy in patients with obesity. LBW-based induction doses of ciprofol improved cardiovascular stability and respiratory safety, whereas IBW-based induction doses of ciprofol reduced respiratory depression. This study was registered in the Chinese Clinical Trial Registry (ChiCTR2300073539 first registration date 13/07/2023).

25 September 2025 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
YZYanjing Zhang
Yanjing Zhang
ZCZhiqiang Chen
Zhiqiang Chen
YCYe Cheng
Ye Cheng
YZYuxuan Zhou
Yuxuan Zhou
YYYaoheng Yang
Yaoheng Yang
YLYalan Li
Yalan Li
Osteoarthritis (OA) is a degenerative joint disease characterised by cartilage breakdown, leading to pain and reduced quality of life. This study aims to investigate the therapeutic potential of Puerarin (PUE), a natural compound derived from Pueraria lobata , in modulating OA progression. Employing a multifaceted approach that included bioinformatics analysis, molecular docking, in vitro assays, and in vivo experiments, we identified 57 overlapping targets between PUE and OA‐related genes, suggesting a multi‐target interaction model. Our findings revealed that PUE effectively inhibited inflammatory cytokine production and protected chondrocytes from apoptosis at non‐cytotoxic concentrations (5 and 10 μM), promoting extracellular matrix synthesis by reversing IL‐1β‐induced degradation of Aggrecan and Collagen II while reducing MMP‐13 and ADAMTS5 expression. Furthermore, PUE was shown to attenuate IL‐1β‐induced apoptosis by restoring BCL‐2 levels and decreasing cleaved caspase‐3 levels. In vivo, PUE administration in a destabilisation of the medial meniscus (DMM) mouse model significantly slowed OA progression, preserving cartilage structure and reducing osteophyte formation. Moreover, PUE activated the PI3K‐AKT signalling pathway, underscoring its anti‐inflammatory and anti‐apoptotic mechanisms. Collectively, these results support Puerarin's potential as a disease‐modifying agent in OA treatment, warranting further clinical exploration and consideration of its application in combination therapies to enhance cartilage protection and repair.